Univeral DX

Madrid-Based Cancer Diagnostics Co. Snags Biggest Spec Suite at Pegasus Park’s Bridge Labs

by | Jan 23, 2025
Founded in 2012, Universal DX is focused on "cracking cancer’s code" via its multi-omics and machine learning models. Starting with colorectal cancer, it's building a "multi-cancer platform" that can ID the unique DNA regions associated with different types of cancers.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.